Inflammatix

$7.5M revenue • 50 employees • United States

Last Updated Oct 3, 2026

Company Overview

Company Name

Inflammatix

Address

United States

Approx. Annual Revenue

$7.5M

Employees

50

Established

2016

About Inflammatix

Inflammatix is a US-based company developing rapid point-of-care diagnostic tests that read the immune response to help physicians better diagnose acute infections and sepsis. Their pipeline includes the Triverity test, which aims to inform on key clinically actionable questions about bacterial or viral infections and the need for intensive care.

Business Profile

Read from the Inflammatix website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current copyright 2026; Clear product and science pages
Footer copyright year
2026

Biotech & Life Sciences Companies near DC

Browse all Biotech & Life Sciences companies →

Frequently Asked Questions about Inflammatix

Categories

Technologies Used

Social Profiles

Key Decision Makers

Tim Sweeney Co-Founder and CEO
LinkedIn
Linda Curtis Clinical Research Associate
LinkedIn